Kenkichi Sugiura Selected Research

azilsartan

4/2022	Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.
4/2022	Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.
6/2014	Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension.
5/2012	Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenkichi Sugiura Research Topics

Disease

4	Hypertension (High Blood Pressure) 04/2022 - 11/2011
2	COVID-19 01/2022 - 01/2022
2	Pain (Aches) 01/2022 - 01/2022
2	Ulcerative Colitis 01/2019 - 01/2019
2	Essential Hypertension 06/2014 - 05/2012
2	Type 2 Diabetes Mellitus (MODY) 02/2013 - 11/2011
1	Acute Kidney Injury (Acute Renal Failure) 04/2022
1	Fatigue 01/2022
1	Multiple Myeloma 01/2022
1	Myalgia 01/2022
1	Crohn Disease (Crohn's Disease) 03/2020
1	Heart Failure 04/2013

Drug/Important Bio-Agent (IBA)

4	azilsartanIBA 04/2022 - 05/2012
3	vedolizumabIBA 03/2020 - 01/2019
3	candesartanIBA 06/2014 - 05/2012
2	Angiotensin Receptor AntagonistsIBA 04/2022 - 05/2012
2	Pioglitazone (Actos)FDA Link 02/2013 - 11/2011
2	candesartan cilexetil (Amias)FDA Link 05/2012 - 11/2011
1	Pharmaceutical PreparationsIBA 04/2022
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2022
1	ixazomibIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	glimepiride (Amarel)FDA LinkGeneric 02/2013
1	TabletsIBA 02/2013
1	LipidsIBA 02/2013

Therapy/Procedure

1	Glycemic Control 02/2013
1	Therapeutics 11/2011